Möchten Sie immer auf dem neuesten Stand bleiben?

PathMaker Neurosystems Receives FDA Breakthrough Device Designation For Non-Invasive Treatment of ALS Using the MyoRegulator® Neuromodulation Device

BRISBANE, Australia and CAMBRIDGE, Mass., Dec. 14, 2025 (GLOBE NEWSWIRE) -- Australian biotechnology pioneer Vaxxas Pty Ltd, has been granted a licence by the Therapeutic Goods Administration...

Free zones in DR reach 200k jobs and keep growing

BioStem Technologies® to Debut American Amnion™ at the 2025 Desert Foot Multi-Disciplinary Limb Salvage and Wound Care Conference

EXTON, Pa., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Lungpacer Medical, a leader in innovative respiratory care neurostimulation technologies, today announced that physicians at one of the nation’s largest...

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "Percutaneous Nephrolithotomy Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" has been added to ...

Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "Breast Pump Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's...

Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System

Dublin, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The "Medical Device Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering.This report contains a comprehensive...

BioStem Technologies Expands Product Access in Medicaid